I'd also like to chime in that the path looks a lo
Post# of 36536
Not only are they talking about a Covid vaccine now, but a Swine Flu Vaccine. Two major deals signed. We knew about both basically, but now signed, now moving forward.
The interesting thing about the Swine Flu, Generex already has experience there. So, this area will not be new for them like Covid is.
You then have AE37 which Generex / NGIO has already experience in and you have Excellegen as well.
Add NGIO listing hopefully coming this year and I think the future looks really bright now.